Morphic News

Morphic Fund Navigates Ethical Investing Amid Market Volatility

TipRanksMay 9 22:37

Morphic to Participate in RBC Capital Markets Global Healthcare Conference

WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chron

MorphicMay 8 23:00

Morphic Ethical Continues Share Buy-Back

TipRanksMay 8 18:57

Morphic Fund Advances Share Buy-Back Effort

TipRanksMay 6 19:18

Morphic Ethical Fund Continues Stock Buy-Back

TipRanksMay 5 19:47

Future Generation's Holdings Decrease in Morphic Fund

TipRanksMay 3 01:48

Morphic Fund Reports Change in Major Shareholder

TipRanksMay 3 01:48

Morphic Ethical Fund Continues Share Buy-Back

TipRanksMay 2 19:18

Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation

Yahoo FinanceMay 1 06:32

Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)

TipRanksApr 30 01:21

Morphic Fund Completes Share Buy-Back

TipRanksApr 29 03:07

Morphic Holding Launches New Stock Offering, Ends Previous Deal

TipRanksApr 26 16:43

Morphic Holding Files Automatic Mixed Shelf

Seeking AlphaApr 26 16:34

Stifel Nicolaus Remains a Hold on Morphic Holding (MORF)

TipRanksApr 26 06:52

Morphic Holding (MORF) Gets a Buy From RBC Capital

TipRanksApr 26 05:36

Morphic Holding's Buy Rating Affirmed: Promising Trials and Strong Financial Outlook

TipRanksApr 26 04:22

Morphic Holding (MORF.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $521,000; earnings per share of -0.91 dollars, previous value of -0.90 dollars, expected value of -0.93 dollars.

Morphic Holding (MORF.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $521,000; earnings per share of -0.91 dollars, previous value of -0.90 dollars, expected value of -0.93 dollars.

Zhitong FinanceApr 25 08:42

Morphic Holding Inc (MORF) Q1 2024 Earnings: A Detailed Review

Yahoo FinanceApr 25 07:37

Morphic Therapeutic Ended First Quarter With $658.8M In Cash, Cash Equivalents, And Marketable Securities; Cash Runway Into Second Half Of 2027

Morphic Therapeutic Ended First Quarter With $658.8M In Cash, Cash Equivalents, And Marketable Securities; Cash Runway Into Second Half Of 2027

BenzingaApr 25 06:31

Morphic Holding Q1 2024 GAAP EPS $(0.91) Beats $(0.94) Estimate

Morphic Holding (NASDAQ:MORF) reported quarterly losses of $(0.91) per share which beat the analyst consensus estimate of $(0.94) by 3.19 percent. This is a 1.11 percent decrease over losses of $(0.90

BenzingaApr 25 06:31